home / stock / antx / antx short
Short Information | AN2 Therapeutics Inc. (NYSE:ANTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 300 |
Total Actual Volume | 1,725,049 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 15 |
Average Short Percentage | 0.00% |
Is there a ANTX Short Squeeze or Breakout about to happen?
See the ANTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2018 | $55.00 | $57.61 | $57.71 | $53.8601 | 1,725,049 | 300 | 0.02% |
News, Short Squeeze, Breakout and More Instantly...
AN2 Therapeutics Inc. Company Name:
ANTX Stock Symbol:
NYSE Market:
2024-04-02 05:30:04 ET JMP Securities analyst issues OUTPERFORM recommendation for ANTX on April 2, 2024 02:23AM ET. ANTX was trading at $3.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recom...
Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) continues with Phase 2 topline results expected in summer 2024 and Phase 3 enrollment pause in place during continued analysis of incoming data; plan to discuss with FDA Cash, cash equivalents, and inve...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...